Clinical Trial Update: Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of trebananib (AMG 386) in combination with paclitaxel and carboplatin for ovarian cancer, fallopian tube cancer, and primary peritoneal cancer ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Trebananib (AMG 386) (trebananib)

Snippet

Sponsor: Amgen | Conditions: Carcinoma, Fallopian Tube Cancer | Phase 1 | Status: COMPLETED